The myth of incompatibility of gentamicin and heparin revisited

Bahar Bastani1

  • 1Division of Nephrology, Department of Internal Medicine, Saint Louis University School of Medicine, Saint Louis, Missouri, USA. bastanib@slu.edu

Journal of Nephrology
|July 13, 2010
PubMed
Abstract

Insights

Gentamicin and heparin mixtures are stable for up to 4 weeks at 4°C, retaining antibiotic and anticoagulant properties. This finding supports their use in hemodialysis catheter lock solutions for infection prevention.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Nephrology

Background:

  • Previous studies advised against mixing gentamicin and heparin due to potential precipitation and incompatibility.
  • The antibiotic lock technique for hemodialysis catheters has increased interest in antibiotic-heparin mixtures.

Purpose of the Study:

  • To re-evaluate the compatibility and stability of gentamicin-heparin mixtures for potential use in hemodialysis catheter lock solutions.

Main Methods:

  • A mixture of gentamicin (100 µg/mL) and heparin (5,000 U/mL) in normal saline was prepared.
  • The mixture was stored at 4°C for up to 4 weeks.
  • Gentamicin concentration, bactericidal activity, and heparin anticoagulant activity were assessed at intervals.

Main Results:

  • No turbidity or precipitation was observed in the gentamicin-heparin mixture during 4 weeks of storage at 4°C.
  • Gentamicin concentration and bactericidal activity remained stable throughout the storage period.
  • Heparin anti-Xa activity showed no significant change after 4 weeks of storage.

Conclusions:

  • In vitro experiments demonstrate that gentamicin and heparin mixtures are stable for up to 4 weeks at 4°C.
  • The mixture retains its gentamicin concentration, bactericidal efficacy, and anticoagulant properties.
  • This stability supports the potential use of gentamicin-heparin solutions in antibiotic lock techniques for hemodialysis.

Related Concept Videos

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...